Akshaya Scientifics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.62 Cr
- Revenue Growth 21.36%
- Profit Growth 16.97%
- Ebitda 8.11%
- Net Worth 23.92%
- Total Assets 6.04%
About Akshaya Scientifics
Akshaya Scientifics Private Limited (ASPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 December 2012 and has a history of 12 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.62 Cr.
Ganapathy Sankaran and Miduturu Subrahmanyam serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85191TG2012PTC084864
-
Company No.
084864
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Dec 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Akshaya Scientifics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganapathy Sankaran
|
Director | 17-Dec-2012 | Current |
|
Miduturu Subrahmanyam
|
Director | 17-Dec-2012 | Current |
Financial Performance of Akshaya Scientifics.
Akshaya Scientifics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.36% increase. The company also saw a substantial improvement in profitability, with a 16.97% increase in profit. The company's net worth Soared by an impressive increase of 23.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akshaya Scientifics?
In 2023, Akshaya Scientifics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹66.24 M
₹0
Charges Breakdown by Lending Institutions
- Others : 6.10 Cr
- Hdfc Bank Limited : 0.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2023 | Hdfc Bank Limited | ₹1.66 M | Open |
| 21 Sep 2022 | Hdfc Bank Limited | ₹3.55 M | Open |
| 07 Aug 2015 | Others | ₹6.10 Cr | Open |
How Many Employees Work at Akshaya Scientifics?
Akshaya Scientifics has a workforce of 26 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akshaya Scientifics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akshaya Scientifics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
